Skip to content

Advertisement

You're viewing the new version of our site. Please leave us feedback.

Learn more

BMC Health Services Research

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Pharmaceutical cost and multimorbidity with type 2 diabetes mellitus using electronic health record data

  • Carla Sancho-Mestre1,
  • David Vivas-Consuelo1Email author,
  • Luis Alvis-Estrada2,
  • Martin Romero3,
  • Ruth Usó-Talamantes4 and
  • Vicent Caballer-Tarazona1
BMC Health Services ResearchBMC series – open, inclusive and trusted201616:394

https://doi.org/10.1186/s12913-016-1649-2

Received: 17 March 2016

Accepted: 10 August 2016

Published: 17 August 2016

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
17 Mar 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
10 Aug 2016 Editorially accepted
17 Aug 2016 Article published 10.1186/s12913-016-1649-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Research Centre for Health Economics and Management, Universitat Politècnica de València
(2)
Universidad de Cartagena
(3)
Fundación Salutia
(4)
Valencian Health Department (Conselleria de Sanitat), General Directorate of Pharmacy and Pharmaceutical Products

Advertisement